NCT01461915 Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients Status TERMINATED Phase PHASE2
NCT01417000 Safety and Efficacy of Combination Listeria/GVAX Immunotherapy in Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01410968 A Feasibility and Safety Study of Vaccination With Poly-ICLC and Peptide-pulsed Dendritic Cells in Patients With Metastatic, Locally Advanced, Unresectable, or Recurrent Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1
NCT01303029 Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01272791 Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT01231347 QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE3
NCT01174121 Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer Status RECRUITING Phase PHASE2
NCT01130142 A Study Evaluating IPI-926 in Combination With Gemcitabine in Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01088815 Hedgehog Inhibitors for Metastatic Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE2
NCT01077986 Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01040000 QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT01028495 A Safety and Efficacy Study of RX-0201 Plus Gemcitabine in Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00996333 Study of Gemzar®, Taxotere®, and Xeloda® (GTX) in Patients With Metastatic Pancreatic Cancer (Stage IVB) Status COMPLETED Phase PHASE2
NCT00954525 Intravenous Vitamin C in Combination With Standard Chemotherapy for Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00922896 Trial of Erlotinib, Gemcitabine and Cisplatin in Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT00868114 Direct Tumor Injection KLH-Pulsed Dendritic Cells in Unresectable Pancreatic Cancer Status TERMINATED Phase PHASE2
NCT00844649 Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas Status COMPLETED Phase PHASE3